RB
Robert F Bartlett
CEO and PresidentDirector

Robert F Bartlett insider trades: Pure Bioscience (PURE) stock purchases

CEO and President, Pure Bioscience Last trade Mar 22, 2023 3 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
1
Open-market trades
since 2023
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

1 trade reported on SEC Form 4, newest first

DateStockTypeValue
Mar 22, 2023PURE↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert F Bartlett's insider trades

Robert F Bartlett is CEO and President at Pure Bioscience (PURE). Since Mar 22, 2023, Robert has reported 1 open-market purchase worth $8K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PURE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.